Wednesday, June 26, 2019

Pharma News

Health Europa brings you the latest Pharma News the field of European Healthcare & Social Care Policy.

EMA: Ramp up efforts to ensure EU medicine supply post-Brexit

EMA: Ramp up efforts to ensure EU medicine supply post-Brexit

The European Medicines Agency (EMA) has warned that some companies need to take further action to safeguard the EU medicine supply once the UK...
Medicines for Europe: better access, better health

Medicines for Europe: better access, better health

Medicines for Europe president Marc-Alexander Mahl outlines the challenges facing the generic, biosimilar and value-added medicines industry and its role in achieving sustainable healthcare. Medicines...
Antibiotic treatment should stop to avoid resistance “tipping point”

Antibiotic treatment should stop to avoid resistance “tipping point”

New research from the University of Exeter, UK, shows that if antibiotic treatment continues to be used, patients will pass the “tipping point” of...
Health outcomes and the community pharmacist

Health outcomes and the community pharmacist

Ilaria Passarani, secretary general of PGEU, reflects on the invaluable role of the community pharmacist in improving patient health outcomes in Europe. Every day, some...
Welcome to the Kuopio Center for Gene and Cell Therapy

Welcome to the Kuopio Center for Gene and Cell Therapy

The Kuopio Center for Gene and Cell Therapy is home to the research and development of new innovative medicines. The Kuopio Center for Gene and...
Innovative tissue analysis: Munich spin-off project receives Helmholtz funding

Innovative tissue analysis: Munich spin-off project receives Helmholtz funding

Tissue analysis is an essential tool for investigating diseases and is a mainstay in the field of diagnostics. Conventionally, tissue is fixed, sliced into...
AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney disease

AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney...

The high and increasing unmet patient need in diabetic kidney disease demands new drugs. Betagenon AB has the answer. Globally, approximately 40% of Type 2...
European Medicines Agency prepare pharmaceutical companies for Brexit

European Medicines Agency prepares pharmaceutical companies for Brexit

The European Medicines Agency (EMA) and the European Commission have updated their guidance which will help pharmaceutical companies prepare for the UK’s withdrawal from...
Antibody therapy for migraine prevention set for marketing authorisation

Antibody therapy for migraine prevention set for marketing authorisation

The first monoclonal antibody therapy for migraine prevention, Aimovig, has been recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal...
Oesophageal cancer can be prevented by taking two medications

Oesophageal cancer can be prevented by taking two medications

Taking a combination of an anti-reflux medication and a low dose of aspirin can prevent oesophageal cancer in people at higher risk, according to...
Can antidepressants increase the risk of weight gain?

Can antidepressants increase the risk of weight gain?

A new study published in The BMJ today has found that long term use of antidepressants is linked to the increase in risk of...
European Commission approves single pill for HIV-1 treatment

European Commission approves single pill for HIV-1 treatment

The Janssen Pharmaceutical Companies of Johnson & Johnson have today announced that the European Commission has approved JULUCA® (dolutegravir/rilpivirine), a once daily single pill...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest